Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia

Xiaoyong Tong, Alok R. Khandelwal, Zhexue Qin, Xiaojuan Wu, Lili Chen, Tetsuro Ago, Junichi Sadoshima, Richard A. Cohen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Elevated levels of reactive oxygen species (ROS) in the vascular wall play a key role in the development of neointimal hyperplasia. Nox4-based NADPH oxidase is a major ROS generating enzyme in the vasculature, but its roles in neointimal hyperplasia remain unclear. Objective: Our purpose was to investigate the role of smooth muscle cell (SMC) Nox4 in neointimal hyperplasia. Approach and results: Mice overexpressing a human Nox4 mutant form, carrying a P437H dominant negative mutation (Nox4DN) and driven by SM22α promoter, to achieve specific expression in SMC, were generated in a FVB/N genetic background. After wire injury-induced endothelial denudation, Nox4DN had significantly decreased neointima formation compared with non-transgenic littermate controls (NTg). ROS production, serum-induced proliferation and migration, were significantly decreased in aortic SMCs isolated from Nox4DN compared with NTg. Both mRNA and protein levels of thrombospondin 1 (TSP1) were significantly downregulated in Nox4DN SMCs. Downregulation of TSP1 by siRNA decreased cell proliferation and migration in SMCs. Similar to Nox4DN, downregulation of Nox4 by siRNA significantly decreased TSP1 expression level, cell proliferation and migration in SMCs. Conclusions: Downregulation of smooth muscle Nox4 inhibits neointimal hyperplasia by suppressing TSP1, which in part can account for inhibition of SMC proliferation and migration.

Original languageEnglish
Pages (from-to)185-194
Number of pages10
JournalJournal of Molecular and Cellular Cardiology
Volume89
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Thrombospondin 1
NADPH Oxidase
Hyperplasia
Smooth Muscle
Down-Regulation
Smooth Muscle Myocytes
Cell Movement
Reactive Oxygen Species
Cell Proliferation
Small Interfering RNA
Neointima
Blood Vessels
Messenger RNA
Mutation
Wounds and Injuries
Enzymes
Serum
Proteins

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia. / Tong, Xiaoyong; Khandelwal, Alok R.; Qin, Zhexue; Wu, Xiaojuan; Chen, Lili; Ago, Tetsuro; Sadoshima, Junichi; Cohen, Richard A.

In: Journal of Molecular and Cellular Cardiology, Vol. 89, 01.12.2015, p. 185-194.

Research output: Contribution to journalArticle

Tong, Xiaoyong ; Khandelwal, Alok R. ; Qin, Zhexue ; Wu, Xiaojuan ; Chen, Lili ; Ago, Tetsuro ; Sadoshima, Junichi ; Cohen, Richard A. / Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia. In: Journal of Molecular and Cellular Cardiology. 2015 ; Vol. 89. pp. 185-194.
@article{b44957814c0a47d8a65b261aad62afe5,
title = "Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia",
abstract = "Elevated levels of reactive oxygen species (ROS) in the vascular wall play a key role in the development of neointimal hyperplasia. Nox4-based NADPH oxidase is a major ROS generating enzyme in the vasculature, but its roles in neointimal hyperplasia remain unclear. Objective: Our purpose was to investigate the role of smooth muscle cell (SMC) Nox4 in neointimal hyperplasia. Approach and results: Mice overexpressing a human Nox4 mutant form, carrying a P437H dominant negative mutation (Nox4DN) and driven by SM22α promoter, to achieve specific expression in SMC, were generated in a FVB/N genetic background. After wire injury-induced endothelial denudation, Nox4DN had significantly decreased neointima formation compared with non-transgenic littermate controls (NTg). ROS production, serum-induced proliferation and migration, were significantly decreased in aortic SMCs isolated from Nox4DN compared with NTg. Both mRNA and protein levels of thrombospondin 1 (TSP1) were significantly downregulated in Nox4DN SMCs. Downregulation of TSP1 by siRNA decreased cell proliferation and migration in SMCs. Similar to Nox4DN, downregulation of Nox4 by siRNA significantly decreased TSP1 expression level, cell proliferation and migration in SMCs. Conclusions: Downregulation of smooth muscle Nox4 inhibits neointimal hyperplasia by suppressing TSP1, which in part can account for inhibition of SMC proliferation and migration.",
author = "Xiaoyong Tong and Khandelwal, {Alok R.} and Zhexue Qin and Xiaojuan Wu and Lili Chen and Tetsuro Ago and Junichi Sadoshima and Cohen, {Richard A.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.yjmcc.2015.11.013",
language = "English",
volume = "89",
pages = "185--194",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia

AU - Tong, Xiaoyong

AU - Khandelwal, Alok R.

AU - Qin, Zhexue

AU - Wu, Xiaojuan

AU - Chen, Lili

AU - Ago, Tetsuro

AU - Sadoshima, Junichi

AU - Cohen, Richard A.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Elevated levels of reactive oxygen species (ROS) in the vascular wall play a key role in the development of neointimal hyperplasia. Nox4-based NADPH oxidase is a major ROS generating enzyme in the vasculature, but its roles in neointimal hyperplasia remain unclear. Objective: Our purpose was to investigate the role of smooth muscle cell (SMC) Nox4 in neointimal hyperplasia. Approach and results: Mice overexpressing a human Nox4 mutant form, carrying a P437H dominant negative mutation (Nox4DN) and driven by SM22α promoter, to achieve specific expression in SMC, were generated in a FVB/N genetic background. After wire injury-induced endothelial denudation, Nox4DN had significantly decreased neointima formation compared with non-transgenic littermate controls (NTg). ROS production, serum-induced proliferation and migration, were significantly decreased in aortic SMCs isolated from Nox4DN compared with NTg. Both mRNA and protein levels of thrombospondin 1 (TSP1) were significantly downregulated in Nox4DN SMCs. Downregulation of TSP1 by siRNA decreased cell proliferation and migration in SMCs. Similar to Nox4DN, downregulation of Nox4 by siRNA significantly decreased TSP1 expression level, cell proliferation and migration in SMCs. Conclusions: Downregulation of smooth muscle Nox4 inhibits neointimal hyperplasia by suppressing TSP1, which in part can account for inhibition of SMC proliferation and migration.

AB - Elevated levels of reactive oxygen species (ROS) in the vascular wall play a key role in the development of neointimal hyperplasia. Nox4-based NADPH oxidase is a major ROS generating enzyme in the vasculature, but its roles in neointimal hyperplasia remain unclear. Objective: Our purpose was to investigate the role of smooth muscle cell (SMC) Nox4 in neointimal hyperplasia. Approach and results: Mice overexpressing a human Nox4 mutant form, carrying a P437H dominant negative mutation (Nox4DN) and driven by SM22α promoter, to achieve specific expression in SMC, were generated in a FVB/N genetic background. After wire injury-induced endothelial denudation, Nox4DN had significantly decreased neointima formation compared with non-transgenic littermate controls (NTg). ROS production, serum-induced proliferation and migration, were significantly decreased in aortic SMCs isolated from Nox4DN compared with NTg. Both mRNA and protein levels of thrombospondin 1 (TSP1) were significantly downregulated in Nox4DN SMCs. Downregulation of TSP1 by siRNA decreased cell proliferation and migration in SMCs. Similar to Nox4DN, downregulation of Nox4 by siRNA significantly decreased TSP1 expression level, cell proliferation and migration in SMCs. Conclusions: Downregulation of smooth muscle Nox4 inhibits neointimal hyperplasia by suppressing TSP1, which in part can account for inhibition of SMC proliferation and migration.

UR - http://www.scopus.com/inward/record.url?scp=84952664244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952664244&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2015.11.013

DO - 10.1016/j.yjmcc.2015.11.013

M3 - Article

C2 - 26582463

AN - SCOPUS:84952664244

VL - 89

SP - 185

EP - 194

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -